Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis

Transfusion Medicine

Volumn 9, Issue 1, 1999, Pages 93-97

  Lee, D ^a   Contreras, M ^b   Robson, S C ^c   Rodeck, C H ^d   Whittle, M J ^e  

^a Lancaster Donor Centre   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033104252     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3148.1999.009001093.x     Document Type: Review

References (21)

1. AABB. (1993) Standards for Blood Banks and Transfusion Services, 15th edn. American Association of Blood Banks, Arlington, VA.
2. Bowman, J.M. (1988) The prevention of Rh immunisation. Transfusion Medicine Reviews, 2, 129-150.
3. British Committee for Standards in Haematology. (1996) Guidelines for blood grouping and red cell antibody testing during pregnancy. Transfusion Medicine, 6, 71-74.
4. Commission of the European Communities. (1994) Notes for guidance: core summary of product characteristics for human anti-D immunoglobulin IM. III/34463/92-EN. Committee for Proprietary Medicine Products, Brussels.
5. Ghosh, S. & Murphy, W.G. (1994) Implementation of the Rh prevention programme: a prospective study. Scottish Medical Journal, 39, 147-149.
6. Huchet, J., Dallamagne, S., Huchet Cl, Brossard, M., Larsen, M. & Parnet-Mathieu, F. (1987) Application ante-partum du traitment preventif d'immunisation RhD chez les femmes Rh negatif. Journal of Gynaecological Obstetrics and Biological Reproduction, 16, 101-111.
7. Johnson, P.R.E., Tait, R.C., Austen, E.B., Shwe, K.H. & Lee, D. (1995) The use of flow cytometry in the quantitation and management of large feto-maternal haemorrhage. Journal of Clinical Pathology, 48, 1005-1008.
8. Jones, A.R. & Silver, S. (1958) The detection of minor erythrocyte populations by mixed agglutinates. Blood, 13, 763.
9. Jorgensen, J. (1975) Feto-maternal blødning. MD Thesis, University of Copenhagen.
10. Lee, D. & Rawlinson, V.I. (1995) Multicentre trial of antepartum low-dose anti-D immunoglobulin. Transfusion Medicine, 5, 15-19.
11. Matthews, C.D. & Matthews, A.E.B. (1969) Transplacental haemorrhage: spontaneous and induced abortion. Lancet, I, 694.
12. Mollison, P.L., Engelfriet, C.P. & Contreras, M. (1993) Blood Transfusion in Clinical Medicine. Blackwell Scientific Publications, Oxford.
13. Murphy, M.F & Lee, D. (1993) Dose of anti-D Ig for the prevention of Rh immunisation after RhD incompatible platelet transfusion (letter). Vox Sanguinis, 65, 73.
14. Ness, P.M., Baldwin, M.L. & Nieby, J.R. (1987) Clinical high-risk designation does not predict excess fetal- maternal haemorrhage. American Journal of Obstetrics and Gynecology, 157, 154-158.
15. UK Blood Transfusion Services. (1991) Prescribers' Journal, 31, 137-145.
16. Medical Research Council. (1974) Report of a Working Party on the use of anti-D immunoglobulin for the prevention of iso-immunisation of Rh-negative women during pregnancy. Controlled trial of various anti-D dosages in suppression of Rh sensitisation following pregnancy. British Medical Journal, 2, 75-80.
17. Standing Medical Advisory Committee. (1981) SMAC memorandum on haemolytic disease of the newborn - 1976: - addendum - 1981. Department of Health and Social Security, London.
18. Standing Medical Advisory Committee. (1976) Haemolytic Disease of the Newborn. Department of Health and Social Security, London.
19. Tovey, L.A.D., Townley, A., Stephenson, B.J. & Taverner, J. (1983) The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae. Lancet, 2, 244-246.
20. Vick, S., Cairns, J., Urbaniak, S., Whitfield, C.R. & Raafat, A. (1996) Cost-effectiveness of antenatal anti-D prophylaxis. Health Economics, 5, 319-328.
21. Wagstaff, W. (1978) Practical aspects of anti-D prophylaxis of haemolytic disease of the newborn Association of Clinical Pathologists: Broadsheet 90.